USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth

Participants:

Caleb Bank Senior Product ManagerNuvoAir
Caleb Bank
Senior Product ManagerNuvoAir
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Alexandra Paul Vice President Of Business DevelopmentAccolade, Inc.
Alexandra Paul
Vice President Of Business DevelopmentAccolade, Inc.
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Emily Lewis Global Digital Transformation LeadUCB
Emily Lewis
Global Digital Transformation LeadUCB
Eugene Borukhovich Co-Founder & COOYourCoach Health
Eugene Borukhovich
Co-Founder & COOYourCoach Health
Jim Howard CEOReadout Health
Jim Howard
CEOReadout Health
Kasparas Aleknavicius Medical AdvisorKilo.Health
Kasparas Aleknavicius
Medical AdvisorKilo.Health
Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Mark Grossman
VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Vasyl Pyrozhyk Vice PresidentSMBC
Vasyl Pyrozhyk
Vice PresidentSMBC

About this Meeting

We have seen a significant number of employers starting to incorporate DTx products into their benefits plans (e.g Pear Therapeutics reSET, Freespira, etc). But why is this a good route to market for DTx companies? Is this the first step in the door to start getting real world use of the product to help later explore other avenues? And does it make sense outside the US? Join us in this informal conversation with other peers to discuss: 

  •  What products are a good fit for employer partnerships and why? E.g oncology might be less aligned with the employer-focused route to market compared to MSK pain management or other areas. 
  •  Real examples of successful DTx-employers partnerships. What can we learn from them? 
  •  What are the implications of choosing the employer's route to market? (e.g impact to the evidence generation process, pricing, marketing, organizational structure, etc) 
  •  What are employers’ requirements to partner (e.g clinical and economic evidence, usability, etc)? What are the challenges of these partnerships? 
  •  Are employees actually  engaged with these products?